Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Consumer Products, and Medical Technologies. The company offers active pharmaceutical ingredients, human and finished dosage formulations, generics, branded generics, specialty formulations, biosimilars, vaccines, novel therapeutics, medical devices and technologies, consumer wellness, veterinary, and animal health products. It also provides biological products in the areas of oncology, autoimmune disorders, nephrology, inflammation, rheumatology, hepatology, and infectious diseases; and designs and executes clinical trials across new chemical entities (NCEs), biologics, vaccines, and specialty generics. In addition, the company operates seasonal, skin and healthcare, and food and nutrition products under the Glucon D, Complan, Sugar Free, Nycil, Everyuth, Nutralite, and RiteBite Max Protein brands. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India. Zydus Lifesciences Limited is a subsidiary of Zydus Family Trust.
Low
835.50
High
1,205.00
Low
1,099.40
High
1,120.00
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How Zydus Lifesciences Limited stacks up against its Drug Manufacturers - Specialty & Generic peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ZYDUSLIFE Zydus Lifesciences Limited | 1,110.30 | 0.23% | 24.75 | 44.87 | 1.11 L Cr | 1.50% | 13.99% | 1,205.00 / 835.50 |
| 2 | AARTIDRUGS Aarti Drugs Limited | 418.00 | 0.78% | 19.97 | 20.93 | 3,815 | 5.53% | 20.38% | 534.55 / 318.95 |
| 3 | AARTIPHARM Aarti Pharmalabs Limited | 816.10 | 1.59% | 34.73 | 23.50 | 7,400 | 13.69% | 14.28% | 946.10 / 585.00 |
| 4 | ABBOTINDIA Abbott India Limited | 26,250.00 | 0.50% | 34.55 | 759.88 | 55,774 | 4.25% | 23.36% | 32,900.00 / 25,150.00 |
| 5 | AHCL ANLON HEALTHCARE LIMITED | 14.38 | 0.07% | 5.93 | 2.42 | 764 | 5.95% | 58.02% | 17.27 / 9.08 |
| 6 | AJANTPHARM Ajanta Pharma Limited | 3,650.00 | 0.24% | 40.18 | 90.83 | 45,595 | 6.17% | 30.87% | 3,796.00 / 2,329.90 |
| 7 | AKUMS AKUMS DRUGS AND PHARMA L | 750.00 | 0.39% | 39.37 | 19.05 | 11,483 | 9.97% | 35.62% | 775.00 / 409.30 |
| 8 | ALIVUS Alivus Life Sciences Limited | 1,357.00 | 0.95% | 27.68 | 49.03 | 16,506 | 17.17% | 28.10% | 1,418.00 / 819.00 |
| 9 | ALKEM Alkem Laboratories Limited | 5,395.00 | 0.09% | 29.90 | 180.45 | 64,536 | 2.73% | 7.93% | 5,933.50 / 5,075.00 |
| 10 | AMRUTANJAN Amrutanjan Health Care Limited | 533.25 | 2.22% | 28.56 | 18.67 | 1,541 | 0.38% | 23.27% | 790.95 / 482.80 |
| 11 | APLLTD Alembic Pharmaceuticals Limited | 818.75 | 0.57% | 23.22 | 35.27 | 16,150 | 0.15% | 20.51% | 998.00 / 635.80 |
| 12 | ASTRAZEN AstraZeneca Pharma India Limited | 7,400.00 | 1.43% | 109.07 | 67.85 | 18,500 | 11.24% | 18.49% | 9,849.50 / 7,371.50 |
| 13 | AUROPHARMA Aurobindo Pharma Limited | 1,614.90 | 0.43% | 25.23 | 64.00 | 92,918 | 4.09% | 41.78% | 1,682.40 / 1,016.10 |